UBS Group’s HANSEN MEDICAL, INC. COM NEW HNSN Stock Holding History

UBS Group’s Portfolio HNSN Stock Details HNSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,596	Closed	-$26K	–	8351
2016 Q2	$26K	Buy	6,596 +645	+11%	+$2.46K	﹤0.01%	6093
2016 Q1	$15K	Buy	5,951 +5,696	+2,234%	+$13.6K	﹤0.01%	6426
2015 Q4	$1K	Sell	255 -2,372	-90%	-$7.75K	﹤0.01%	8260
2015 Q3	$10K	Sell	2,627 -756	-22%	-$4.94K	﹤0.01%	7306
2015 Q2	$31K	Buy	3,383 +2,373	+235%	+$21.6K	﹤0.01%	6469
2015 Q1	$9K	Sell	1,010 -3,470	-77%	-$28.2K	﹤0.01%	7780
2014 Q4	$25K	Buy	+4,480	New	+$37.1K	﹤0.01%	7347

UBS Group's HNSN Position: Q3 2016 in Review

UBS Group sold out of HANSEN MEDICAL, INC. COM NEW (HNSN) in Q3 2016, closing a stake of 6,596 shares — an estimated $26K sold.

UBS Group first reported a position in HNSN in Q4 2014 and held it in 7 quarters. The position peaked at $31K in Q2 2015. 0 funds tracked by Wall St. Rank hold HNSN as of Q3 2016.

UBS Group reported no remaining HANSEN MEDICAL, INC. COM NEW position as of Q3 2016 after selling out during the quarter.
UBS Group sold 6,596 HANSEN MEDICAL, INC. COM NEW shares in Q3 2016, an estimated $26K.
UBS Group first reported a position in HANSEN MEDICAL, INC. COM NEW in Q4 2014 and held it in 7 quarters.
UBS Group's HANSEN MEDICAL, INC. COM NEW position peaked at $31K in Q2 2015.
0 funds tracked by Wall St. Rank held HANSEN MEDICAL, INC. COM NEW as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.